Evidence map›Paper›PMID 20977918›Full record

ArticleHuman immunology2011

Interleukin-21 and cellular activation concurrently induce potent cytotoxic function and promote antiviral activity in human CD8 T cells.

Anita Parmigiani, Maria F Pallin, Helena Schmidtmayerova, Mathias G Lichtenheld, Savita Pahwa

Open access · greenAbstract read
In one paragraph

Article in Human immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 49 citations in OpenAlex.

  1. Trial
  2. Interleukin-21 responses in patients with chronic hepatitis B.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2015
    Trial
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Observational
  10. The CD8Microbiology and molecular biology reviews : MMBR · 2021
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Anita ParmigianiDepartment of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, Florida, USA.
Maria F Pallin
Helena Schmidtmayerova
Mathias G Lichtenheld
Savita Pahwa
University of Miami · US

Funding

University of Miami Developmental Center for AIDS Research (D-CFAR)P30AI073961 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI MARIA LUISA ALCAIDE · 2007 to 2026
$33.8M
Role of IL21 in HIV InfectionR01AI077501 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI PAHWA, SAVITA · 2008 to 2011
$1.5M
NIAID NIH HHS 5P30AI073961NIAID NIH HHS AI077501NIAID NIH HHS P30 AI073961NIAID NIH HHS R01 AI077501
6 · The paper itself

Abstract

Infection with human immunodeficiency virus (HIV)-1 induces a progressive deterioration of the immune system that ultimately leads to acquired immune deficiency syndrome (AIDS). Murine models indicate that the common γ-chain (γ(c))-sharing cytokine interleukin (IL)-21 and its receptor (IL-21R) play a crucial role in maintaining polyfunctional T cell responses during chronic viral infections. Therefore, we analyzed the ability of this cytokine to modulate the properties of human CD8 T cells in comparison with other γ(c)-sharing cytokines (IL-2, IL-7, and IL-15). CD8 T cells from healthy volunteers were stimulated in vitro via T cell receptor signals to mimic the heightened status of immune activation of HIV-infected patients. The administration of IL-21 upregulated cytotoxic effector function and the expression of the costimulatory molecule CD28. Notably, this outcome was not accompanied by increased cellular proliferation or activation. Moreover, IL-21 promoted antiviral activity while not inducing HIV-1 replication in vitro. Thus, IL-21 may be a favorable molecule for immunotherapy and a suitable vaccine adjuvant in HIV-infected individuals.

Indexed as

Adjuvants, ImmunologicAnimalsCD28 AntigensCD8-Positive T-LymphocytesCells, CulturedGranzymesHIV-1HIV InfectionsHumansImmunity, CellularInterleukin-15Interleukin-2Interleukin-21Interleukin-7InterleukinsLymphocyte ActivationAdjuvants, ImmunologicCD28 AntigensGranzymesInterleukin-15Interleukin-2Interleukin-21Interleukin-7InterleukinsPerforinReceptors, Antigen, T-Cell

Identifiers

PMID20977918
PMCPMC3042849
OpenAlexW1967181958

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.